SUMO1 and hydrops fetalis: The key regulatory pathway involves extracellular vesicle-associated miR-146a transfer into cardiomyocytes from fibroblasts and suppression of SUMO1 expression, thereby impairing cardiac contractile function and aggravating HF (65).